Quick Answer
ENvue Medical, Inc. reported Net Income Loss of -$3.71 million for the year ending 2024.
- ENvue Medical, Inc. showed an increase of +0.2% in Net Income Loss from 2023 to 2024.
- This data is from ENvue Medical, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2025.
- XBRL data for this metric is available from 2014 to 2024 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2014: -$578.0 thousand | Q3 2014: -$766.0 thousand | Q1 2015: -$630.0 thousand | Q2 2015: -$434.0 thousand | Q3 2015: -$1.04 million | Q1 2016: -$495.0 thousand | Q2 2016: -$610.0 thousand | Q3 2016: -$606.0 thousand | Q1 2017: -$877.0 thousand | Q2 2017: -$849.0 thousand | Q3 2017: -$1.60 million | Q1 2018: -$789.0 thousand | Q2 2018: -$824.0 thousand | Q3 2018: -$1.34 million | Q1 2019: -$2.68 million | Q2 2019: -$1.11 million | Q3 2019: -$815.0 thousand | Q1 2020: -$921.0 thousand | Q2 2020: -$1.48 million | Q3 2020: -$922.0 thousand | Q1 2021: -$4.92 million | Q2 2021: -$216.0 thousand | Q3 2021: -$6.68 million | Q1 2022: -$1.13 million | Q2 2022: -$1.30 million | Q3 2022: -$955.0 thousand | Q1 2023: -$1.10 million | Q2 2023: $500.0 thousand | Q2 2023: -$1.07 million | Q3 2023: -$727.0 thousand | Q1 2024: -$588.0 thousand | Q2 2024: -$688.0 thousand | Q3 2024: -$998.0 thousand | Q1 2025: -$2.50 million | Q2 2025: -$3.97 million | Q3 2025: $510.0 thousand.
- Over the full 11 years of available data (2014 to 2024), ENvue Medical, Inc.'s Net Income Loss has declined by 40.0%.
- Historical annual values: Fiscal year 2024: -$3.71 million | Fiscal year 2023: -$3.71 million | Fiscal year 2022: -$5.45 million | Fiscal year 2021: -$14.28 million | Fiscal year 2020: -$4.33 million | Fiscal year 2019: -$5.79 million | Fiscal year 2018: -$4.15 million | Fiscal year 2017: -$4.97 million | Fiscal year 2016: -$2.83 million | Fiscal year 2015: -$2.88 million | Fiscal year 2014: -$2.65 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: